Legal Representation
Attorney
Kumiko Ide
USPTO Deadlines
Next Deadline
342 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-07-07)
Due Date
July 07, 2026
Grace Period Ends
January 07, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 7, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
May 12, 2022 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
May 12, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
May 12, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
May 12, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
May 12, 2022 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
May 12, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
May 12, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jul 7, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Apr 21, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Apr 21, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 1, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Mar 18, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Mar 17, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 24, 2020 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
Jan 23, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jan 14, 2020 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
Jan 14, 2020 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
Dec 21, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Dec 21, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Providing information to patients in the field of administering medicines; Providing medical information on disease and disease management in the fields of immunology and central nervous system diseases; Patient support and pharmaceutical adherence program in the nature of providing medical information on disease management, patient wellness and assistance to patient in complying with instructions and directions for taking medicines for the treatment of immunology and central nervous system diseases; Providing medical information on disease and disease management in the field of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and central nervous system diseases; Patient support and pharmaceutical adherence program in the nature of providing medical information on disease management, patient wellness and assistance to patient in complying with instructions and directions for taking medicines for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and central nervous system diseases
First Use Anywhere:
20190200
First Use in Commerce:
20190200
Additional Information
Design Mark
The mark consists of the word "UCBCARES" underneath which are the words "CARING ANSWERS" in cursive font.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
UCB CARES CARING ANSWERS
Classification
International Classes
044